We are developing a computer software called CASP (Computer Aided Surgical Planning) that will enable cardiologists to use artificial intelligence as a tool in daily clinical practice when planning the optimal placement of implants used during heart bypass surgery.
The idea has stemmed from the latest advances in biotechnology research that has driven computational fluid dynamics into the forefront of tools used by engineers when designing medical devices used for treating cardiovascular diseases.
The founders’ vision was to commercialise an innovative computer software capable of determining the optimal placement of implants used during heart bypass surgery. The software enables tailored treatment for patients and creates improved clinical outcomes.
Following the success of the founders in developing novel implants for treating cardiovascular disease in 2016 (www.HeliRidgeGraft.com), the founders have gone on to be awarded £151,000 from the Medical Research Council to develop and prove the concept of CASP in collaboration with Central Manchester University Teaching Hospital Trust.